‘A slow-moving glacier’: NIH’s sluggish and often opaque efforts to study long Covid draw patient, expert ire
WASHINGTON — The National Institutes of Health is fumbling its first efforts to study long…
Category: coronavirus
Opinion: Unexpectedly united: The parallel plights of two communities 2,000 miles apart wracked by the pandemic
I constantly straddle two disparate worlds. One is in Boston, where I work for one…
Officials limit an antibody therapy, saying it’s ineffective against BA.2 variant of Omicron
U.S. health officials on Friday stopped the further deployment of the Covid-19 treatment sotrovimab to…
Opinion: How we got herd immunity wrong
Herd immunity was always our greatest asset for protecting vulnerable people, but public health failed…
Listen: Helen Branswell on the evolving pandemic, plus the next FDA debate and the perks of being a CEO
Are Covid-19 vaccines a sustainable business? Was Aduhelm an aberration? And what comes after Omicron?…
Moderna to ask FDA to authorize Covid-19 vaccine in children 6 months to 6 years
Moderna announced Wednesday that it will ask the Food and Drug Administration to authorize its…
New Covid trial results may point toward better ways to study medicines
The battle against Covid-19 has been marked by false hope, as too many people embraced…
‘I fear the long-term effects’: Before his death, a nurse warned of the pandemic’s toll on health care workers
In early 2020, Michael Odell sensed that Covid-19 would hit hard. A young intensive care…
Opinion: Covid-19 vaccine policy should be made by public health experts, not company executives
In a March 13 interview with CBS, Albert Bourla, Pfizer’s CEO, said his company intended…
STAT+: Pfizer inks deal with UNICEF to supply Covid pill to poor countries, but advocates say it isn’t enough
As part of an effort to widen access to its Covid-19 pill, Pfizer has reached…
The Covid-19 vaccine market is getting crowded — as demand begins to wane
CureVac, a pioneer in the effort to use messenger RNA as a vaccine platform, and…
Opinion: Biden administration (finally) elevates healthy buildings as part of national Covid strategy
The White House announcement on Thursday that it is elevating “clean air in buildings” as…
The new White House Covid coordinator is great on TV. Is that what America’s pandemic response needs now?
WASHINGTON — When it comes to discussing the White House’s pandemic response on TV, there’s…
‘Is it worth it?’: New report lays bare harassment of public health officials during the pandemic
There’s a mountain of evidence showing the devastating toll of the pandemic on health workers….
Listen: Doing biotech in Ukraine, drug pricing déjà vu, & Covid surges overseas
How should pharma treat Russia? Why can’t Congress pass a drug pricing bill? And what…
Ashish Jha to replace Jeff Zients as White House Covid response coordinator
WASHINGTON — President Biden is replacing Covid response coordinator Jeff Zients with Ashish Jha, the…
With infections spiking in Europe and a variant on the rise, experts warn the U.S. could face a Covid resurgence
On the surface, U.S. Covid-19 metrics continue to show improvement, with cases, hospitalizations, and deaths…
STAT+: A compromise is reached on an intellectual property waiver for Covid-19 vaccines, but does it go far enough?
After 18 months of talks, a compromise was reached on a proposal to waive intellectual…
Inside the push for a permanent pandemic preparedness office at the White House
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
White House begs Congress for Covid funding amid concern about Omicron sister variant
WASHINGTON — The White House is begging Congress for more funds to help with Covid-19 surveillance,…
‘Haven’t we learned anything?’: Experts warn of disastrous consequences if pandemic funding dries up
WASHINGTON — The failure of Congress this week to approve additional pandemic response funding could…
Listen: Gilead’s growing pains, Covid’s origins, & Theranos as prestige TV
Can biotech companies age gracefully? Where did Covid-19 come from? And does Theranos make for…
Opinion: Ignoring behavioral and social sciences undermines the U.S. response to Covid-19
The U.S. has bungled many of its efforts to rein in the Covid-19 pandemic. We…
Nurses, more powerful and visible after Covid, capitalize on new clout in Washington
WASHINGTON — Since the start of Covid-19, nurses have been hailed as heroes. But two…
Covid budget crunch looms over government funding fight
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
.jpg)
Prisons skimp on Covid treatments like Paxlovid, even as Biden plans to flood pharmacies with it
WASHINGTON – Pfizer’s antiviral drug Paxlovid seems tailor-made for combatting Covid-19 in prisons: It doesn’t…
.jpg)
Florida’s decision on Covid vaccines for healthy kids adds to confusion and distrust
Florida Surgeon General Joseph Ladapo announced Monday that the state will recommend that healthy children…
‘We’re all in this together’: As long Covid studies continue, researchers cast a wider net
There are almost as many questions about long Covid as there are symptoms. From the…
Public health experts sketch a roadmap to get from the Covid pandemic to the ‘next normal’
A new report released Monday charts a path for the transition out of the Covid-19…
White House transparency disputes imperil funds to buy Covid therapeutics
WASHINGTON — The White House hasn’t publicly detailed exactly how it’s spent the more than…
Opinion: Health care workers don unnecessary protective gear. The CDC and WHO need to update their PPE guidance
Every time we enter a Covid patient’s room, we first don gloves, and a disposable…
The pandemic: a series of failures, a few miracles — and a lesson for next time, global health experts say
As the nation exhales at the sight of descending curves of Covid-19 infection and death, top…
Listen: Biden’s plans for Covid pills, the latest vaccine data, & fighting about CRISPR
Is “test to treat” too good to be true? Does it really matter who gets…
STAT+: Why formally ending the pandemic is going to be a huge headache for the entire health care system
WASHINGTON — President Biden made it clear this week he wants to transition toward a…
As Omicron recedes, White House shifts to a more targeted Covid strategy
WASHINGTON — The threat of the Omicron variant is receding and cities around the country…
In State of the Union, Biden walks a fine line on Covid optimism
WASHINGTON — President Biden on Tuesday vowed that the U.S. won’t become complacent in its…
CDC data suggest Pfizer vaccine protection holds up in kids 5-11, raising questions on earlier study
Does the Pfizer-BioNTech Covid-19 vaccine provide less protection to children aged 5 to 11 than…
The FDA’s promised menthol ban is about to face a critical test
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
STAT+: Pfizer made Trump’s vaccine push harder than it needed to be, former Warp Speed official alleges in new book
WASHINGTON — Pfizer may have been the first company to deliver on the promises of…
Pfizer Covid vaccine is less effective in kids 5 to 11, study finds
Newly emerging data suggest the Pfizer-BioNTech Covid vaccine works substantially less well at preventing infection…
Listen: Medical racism, new Covid vaccines, & the resilience of Regeneron
How many Covid-19 vaccines does the world really need? What will it take to address…
Listen: Biotech in 2022, the Omicron surge, & the Elizabeth Holmes verdict
How worrisome is Omicron? Are the vibes off in biotech? And does the Theranos verdict…
Scientists try to pinpoint why rapid Covid tests are missing cases
Marianna Parker, a Boston-area pediatrician, wanted to make sure she, her husband, and her toddler…
STAT+: Chilean health ministry is urged to issue a compulsory license for the Pfizer Covid pill
In the latest bid to expand access to the Pfizer (PFE) Covid-19 pill, a nonprofit…
STAT+: Institutional investors urge pharma boards to tie executive compensation to global Covid vaccine equity
More than 65 institutional investors are urging the directors of companies making Covid-19 vaccines to…
Opinion: Containing Covid-19 requires rapid tests that are highly sensitive to infections. Why is the FDA asking for something different?
With rapid testing becoming a key tool in the fight against Covid-19, in a mid-October…
CDC advisers recommend teens 12 to 17 should receive a Covid-19 booster shot
An expert panel that advises the Centers for Disease Control and Prevention on vaccines voted…
Study raises doubts about rapid Covid tests’ reliability in early days after infection
A new study raises significant doubts about whether at-home rapid antigen tests can detect the…
Opinion: ‘Protect our hospitals’ might convince Britons to get Covid-19 vaccines, but it won’t work in the U.S.
The resurgence of Covid-19 is again leading health care systems across the globe to brace…
Covid-19 politics force state lawmakers to ponder pharma campaign cash
WASHINGTON — Ohio state Rep. Beth Liston had accepted campaign donations from Pfizer before, but…